San Francisco, CA - endpoint, an interactive response technology (IRT) solutions provider, introduces its new clinical supply management tool DRIVE, which enables IRT functionality for non-IRT and Investigator-Sponsored Trials (IIT). DRIVE will be unveiled at the Drug Information Association (DIA) Annual Meeting, June 26-30, in Philadelphia. DRIVE delivers the benefits of IRT supplies management to the entire development program, including early-phase non-IRT and IIT, in one system - saving sponsors and sites time, reducing waste and optimizing the supply chain. Features include:
“While individual, stand-alone IRT systems for patient and supplies management are not warranted for every study, the challenge of managing supplies across IRT and non-IRT studies, including IIT, remains a sponsor pain point. To alleviate this issue, endpoint has developed DRIVE, a dynamic, easy-to-use clinical supply management hub,” said Chuck Harris, general manager. “DRIVE reflects endpoint’s commitment to addressing our industry’s challenges with novel, SaaS-based solutions.” endpoint will also be unveiling its new brand, which showcases endpoint’s services and technology by both highlighting the company’s proven expertise and emphasizing PULSE as a reliable IRT solution. Stop by Booth 501 at DIA or
schedule a meeting
to ask about endpoint’s feature-rich supply chain and clinical management tools and see how it gets
Straight to the Point
.
About endpoint
endpoint is focused primarily on providing interactive response technology (IRT) systems and solutions that support the life sciences industry. endpoint’s proprietary IRT system configuration engine, PULSE, provides non-technical users with the necessary tools to design and deploy customized IRT solutions in just four weeks. Having a team with up to 20 years of industry experience and headquartered in San Francisco, endpoint has been developing IRT systems since 2009. See how our flexible IRT solution meets the unique needs of any clinical trial at
www.endpointclinical.com
.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.